A healthcare-associated infection (HAI) is any infection acquired in a clinic, hospital, long-term care facility, or other healthcare delivery site.
This comprehensive medical market and technology report provides an overview and in-depth market analysis of implantable cardioverter defibrillators (ICDs) used to treat forms of cardiac arrhythmia and heart failure (HF).
This Meddevicetracker report provides an analysis of the market for specialty endoscopic surgery devices (including access devices, endoscopes and equipment, hand instruments, and suction/irrigation and fluid management systems). Geographic segments covered include the US, five major EU markets, Japan, and the rest of the world.
This report provides an unparalleled 120-country statistical view of the US$36.4 billion orthopaedic device markets. Comprising a pdf report and data set in MS Excel™, the report is rich in stats, tables and graphs and covers market value, market growth in US$/local currency and per capita spending over the last 10 years with 5-year forecasts to 2023 for the trade segments of artificial joints and other orthopaedic products.
Valued at more than $7.7bn in 2018, the Global Hearing Aids Market is growing at a healthy pace—in the upper single-digits, at a compound annual growth rate (CAGR) of nearly 7.5%. Growth will be driven by the increasing global prevalence of hearing loss. According to the World Health Organization (WHO), approximately 466 million people have disabling hearing loss worldwide, including 34 million who are children, and this number is expected to grow to nearly 630 million by 2030.
This Meddevicetracker report provides an analysis of the market for general and pelvic endoscopic surgery products in the US, five major EU markets, Japan, and the rest of the world. Market segments covered include access devices, access site closure devices, ancillary devices, endoscopes, hand instruments, and insufflation products.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the surgical heart valve repair (annuloplasty) systems, surgical heart valve replacement products, and percutaneous balloon valvuloplasty (PBV) systems markets.
This report provides a global view of key statistics of 165 technology markets around the world. Rich in stats, tables and graphs the report includes ranking tables for key performance indicators, economic, social and medical trade information, currency exchange impacts (US$ and local currency), and 10 year trend data for key sectors such as diagnostic imaging, disability products, medical/surgical consumables and orthopaedic products.
This Meddevicetracker report provides an analysis of the market for arthroscopy products (including visualization systems, fluid management equipment, and manual and powered instruments) and sports medicine/soft tissue fixation implants for the US, five major EU markets, Japan, and the rest of the world.
Arterial blood gases are the most commonly ordered test in critical care settings such as ICUs and ORs.Tests with rapid turnaround times, such as POC tests, are largely replacing the slower laboratory test market.
This report includes: an overview of hearing loss, cochlear implant technology, competition, trends, and market analysis. Market analysis includes 5-year market forecast by region, market drivers/limiters, global market share and market share by region.
This Meddevicetracker analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the market for bone densitometers (including DXA, QUS, QCT, RA, and SXA systems) and bone turnover marker tests for the US, the five major EU markets, Japan, and the rest of world markets.
This 11-question pulse survey of 74 dermatologists practicing throughout the US and Europe asks respondents their thoughts on results from the ECLIPSE study
The 60th American Society of Hematology (ASH) Annual Meeting and Exposition was held in San Diego, CA from December 1-4, 2018.
This 9-question pulse survey of 102 hematologic oncologists practicing throughout the United States and Europe.
The market for molecular in vitro diagnostic and screening tests for oncology totaled approximately $1.0bn in 2017, and is projected to expand at a compound annual growth rate (CAGR) of 13.1% during 2017-22, reaching an estimated $1.9bn.
Valued at approximately $1.1bn in 2017, the implantable Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS) Device Markets are two important and growing neuromodulation segments (outside of the largest, most dynamic $2.5bn segment, Spinal Cord Stimulation or SCS).
This report provides analysis of the global market for liquid biopsy products for the diagnosis and management of cancer. Regions covered by this report include North America, Europe, Asia Pacific, and the rest of the world (which combines estimated sales data for all other countries).
The global market for joint replacement implants, which includes prostheses for the hips, knees, shoulders, elbows, ankles, and small joints, totaled nearly $16.4bn in 2017. This market is projected to increase at a compound annual growth rate of 3.8%, reaching nearly $19.8bn in 2022.
Valued at approximately $380m in 2017, the Surgical Ablation Devices Market for Oncology is expanding at a double-digit rate, driven by the increasing global prevalence of cancer and the growing demand for better healthcare in emerging markets.
The global market for diagnostic electrocardiograph products is anticipated to see high, single-digit growth throughout the forecast period covered by this analysis (2017-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually.
The large and burgeoning global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide. Despite lingering economic uncertainty and financial constraints that have affected many other medical device markets, this market is undergoing significant technological advancement due to heavy R&D and investment efforts by dozens of innovative startups and leading medical device companies.
The global market for atherectomy and thromboembolectomy products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2016-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually.
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.
This medical market and technology report provides a comprehensive discussion of implanted instrumentation for spinal fusion.
The global market for vascular stents is being driven by the increasing prevalence of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually.
This report provides an overview of pulse oximetry, and profiles selected leading products and technologies. The report also provides a market and competitive analysis of the global pulse oximetry devices market, including five-year market forecast and share by supplier.
This report presents procedure volumes forecasts for some of the most common surgical procedures performed in the five EU countries of France, Germany, Italy, Spain, and the UK (5EU).
This report presents procedure volumes forecasts for some of the most common orthopedic and spine surgical procedures performed in the five EU countries of France, Germany, Italy, Spain, and the UK (5EU). The forecast period covered by this report is for the years 2016 through 2021.
This report presents procedure volumes forecasts for some of the most common cardiovascular and peripheral vascular surgical procedures performed in the five EU countries of France, Germany, Italy, Spain, and the UK (5EU). The forecast period covered by this report is for the years 2016 through 2021.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!